Unknown

Dataset Information

0

Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.


ABSTRACT: Background:Transplant practices related to use of organs from Hepatitis C virus infected donors (DHCV+) is evolving rapidly.

Methods:We surveyed U.S. kidney transplant programs by email and professional society listserv postings between 7/19-1/20 to assess attitudes, management strategies, and barriers related to use of viremic (nucleic acid testing (NAT)+) donor organs in HCV uninfected recipients.

Results:Staff at 112 unique programs responded, representing 54% of U.S. adult kidney transplant programs and 69% of adult deceased donor kidney transplant volume in 2019. Most survey respondents were transplant nephrologists (46%) or surgeons (43%). Among responding programs, 67% currently transplant DHCV antibody+/NAT- organs under a clinical protocol or as standard of care. By comparison, only 58% offer DHCV NAT+ kidney transplant to HCV- recipients, including 35% under clinical protocols, 14% as standard of care, and 9% under research protocols. Following transplant of DHCV NAT+ organs to uninfected recipients, 53% start direct acting antiviral agent (DAA) therapy after discharge and documented viremia. Viral monitoring protocols after DHCV NAT+ to HCV uninfected recipient kidney transplantation varied substantially. 56% of programs performing these transplants report having an institutional plan to provide DAA treatment if declined by the recipient's insurance. Respondents felt a mean decrease in waiting time of ?18 months (range 0-60) justifies the practice. Program concerns related to use of DHCV NAT+ kidneys include insurance coverage concerns (72%), cost (60%), and perceived risk of transmitting resistant infection (44%).

Conclusions:Addressing knowledge about safety and logistical/financial barriers related to use of DHCV NAT+ kidney transplantation for HCV uninfected recipients may help reduced discards and expand the organ supply.

SUBMITTER: Lentine KL 

PROVIDER: S-EPMC7695231 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers.

Lentine Krista L KL   Peipert John D JD   Alhamad Tarek T   Caliskan Yasar Y   Concepcion Beatrice P BP   Forbes Rachel R   Schnitzler Mark M   Chang Su-Hsin SH   Cooper Matthew M   Bloom Roy D RD   Mannon Roslyn B RB   Axelrod David A DA  

Kidney360 20201125 11


<h4>Background</h4>Transplant practices related to use of organs from Hepatitis C virus infected donors (DHCV+) is evolving rapidly.<h4>Methods</h4>We surveyed U.S. kidney transplant programs by email and professional society listserv postings between 7/19-1/20 to assess attitudes, management strategies, and barriers related to use of viremic (nucleic acid testing (NAT)+) donor organs in HCV uninfected recipients.<h4>Results</h4>Staff at 112 unique programs responded, representing 54% of U.S. ad  ...[more]

Similar Datasets

| S-EPMC7033844 | biostudies-literature
| S-EPMC9751709 | biostudies-literature
| S-EPMC7594852 | biostudies-literature
| S-EPMC5239985 | biostudies-literature
| S-EPMC6309394 | biostudies-other
| S-EPMC5534365 | biostudies-other
| S-EPMC6860390 | biostudies-literature
| S-EPMC4840104 | biostudies-literature
| S-EPMC3683983 | biostudies-literature